Dashboard
With a Operating Losses, the company has a Weak Long Term Fundamental Strength
- Poor long term growth as Net Sales has grown by an annual rate of 9.56% over the last 5 years
- Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of -0.71
Flat results in Sep 25
Risky - Negative EBITDA
Stock DNA
Pharmaceuticals & Biotechnology
INR 52 Cr (Micro Cap)
NA (Loss Making)
52
0.00%
-0.01
-0.10%
0.47
Total Returns (Price + Dividend) 
Rajnish Wellness for the last several years.
Risk Adjusted Returns v/s 
Returns Beta
News

Rajnish Wellness Stock Falls to 52-Week Low of Rs.0.66 Amidst Weak Financial Indicators
Rajnish Wellness has reached a new 52-week low of Rs.0.66, marking a significant decline in its stock price amid subdued financial performance and ongoing market pressures. The stock has underperformed its sector and broader market indices, reflecting challenges in its recent business metrics.
Read More
Rajnish Wellness Stock Falls to 52-Week Low of Rs.0.67
Rajnish Wellness, a player in the Pharmaceuticals & Biotechnology sector, has reached a new 52-week low of Rs.0.67, marking a significant decline in its stock price amid broader market fluctuations and company-specific performance factors.
Read More
Rajnish Wellness Stock Falls to 52-Week Low of Rs.0.67 Amidst Weak Financial Indicators
Rajnish Wellness, a player in the Pharmaceuticals & Biotechnology sector, has reached a new 52-week low of Rs.0.67, reflecting ongoing pressures on its stock price amid subdued financial performance and market conditions.
Read More Announcements 
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
09-Jan-2026 | Source : BSECertificate under Regulation 74 (5) of SEBI (DP) Regulations 2018.
Closure of Trading Window
26-Dec-2025 | Source : BSEIntimation of Closure of Trading Window.
Expansion Of Medical Franchise Network
22-Dec-2025 | Source : BSERajnish Wellness Limited is please to inform about its continued expansion in the Pharmaceuticals and healthcare distribution segment through its medical franchise brand Dava Discount.
Corporate Actions 
No Upcoming Board Meetings
No Dividend history available
Rajnish Wellness Ltd has announced 1:2 stock split, ex-date: 10 Jan 23
Rajnish Wellness Ltd has announced 2:1 bonus issue, ex-date: 21 Jul 22
Rajnish Wellness Ltd has announced 19:30 rights issue, ex-date: 03 Jun 25
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Dec 2025
Shareholding Compare (%holding) 
Non Institution
None
Held by 0 Schemes
Held by 1 FIIs (0.43%)
Rajnish Kumar Singh (9.16%)
None
85.39%
Quarterly Results Snapshot (Standalone) - Sep'25 - QoQ
QoQ Growth in quarter ended Sep 2025 is 163.16% vs -20.97% in Jun 2025
QoQ Growth in quarter ended Sep 2025 is -72.73% vs 147.83% in Jun 2025
Half Yearly Results Snapshot (Standalone) - Sep'25
Growth in half year ended Sep 2025 is -50.89% vs 24.80% in Sep 2024
Growth in half year ended Sep 2025 is -36.36% vs -32.31% in Sep 2024
Nine Monthly Results Snapshot (Standalone) - Dec'24
YoY Growth in nine months ended Dec 2024 is -12.05% vs 153.47% in Dec 2023
YoY Growth in nine months ended Dec 2024 is -32.00% vs -47.92% in Dec 2023
Annual Results Snapshot (Standalone) - Mar'25
YoY Growth in year ended Mar 2025 is -36.67% vs 206.35% in Mar 2024
YoY Growth in year ended Mar 2025 is -83.50% vs 123.91% in Mar 2024